Login / Signup

Long-term follow-up of 415 patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide-based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials: A comprehensive assessment of prognostic factors.

David John AllsupZoe CraigDavid CairnsDena HowardAnna HockadayAdrian BloorZarni SoeChristopher PepperValter GatteiAntonella ZucchettoPauline RobbeRuth CliffordAnna SchuhTalha MunirAndrew RawstronPeter Hillmen
Published in: American journal of hematology (2022)
Keyphrases
  • prognostic factors
  • chronic lymphocytic leukemia
  • climate change
  • low dose
  • high dose
  • newly diagnosed
  • clinical evaluation